Human Chorionic Gonadotropin (hCG) Testing in Specimens of Tumor and Myometrial Tissues During Surgical Treatment of Gestational Trophoblastic Tumors

• Reda Hemida

  Department of Obstetrics & Gynecology, Faculty of Medicine, Mansoura University, Egypt

• Mohammad Arafa

  Department of Pathology, Faculty of Medicine, Mansoura University, Egypt

• Hosam AbdElfattah

  Department of Obstetrics & Gynecology, Faculty of Medicine, Mansoura University, Egypt

• Doaa Sharaf-Eldin

  Department of Clinical Oncology & Nuclear Medicine, Faculty of Medicine, Mansoura University, Egypt

 Background: Gestational trophoblastic tumors originate from trophoblastic tissues and secrete human chorionic gonadotrophin (hCG). Surgical treatment may be a line of treatment of chemoresistant cases.

Objective: To evaluate the accuracy of hCG dipsticks in detection of hCG in tissues of trophoblastic tumors and healthy myometrium during surgery of trophoblastic tumors.

Methods: We included 19 samples of tumor and apparently healthy myometrial tissues during surgical treatment of 5 cases of gestational trophoblastic tumors. The hCG dipstick was immersed in a solution containing 1x1 cm of tumor or myometrial tissues. The results of the tests were compared to the histopathological results.

Results: The mean age of patients were 38.8 years, the mean parity was 3.4. The mean serum B-hCG level was 101,745.6 mu/ml. Except for one specimen in case 5, all results of the hCG dipsticks were concordant with final histopathologic analysis of the specimens. Sensitivity of hCG test was 100% and specificity was 90%.

Conclusion: Intraoperative detection of hCG in different tissues and suspicious masses can be considered as simple, rapid, inexpensive, and reliable test. It can be used to detect the trophoblastic nature of tissues if frozen section is not available as some low resource setting countries. We recommend further larger prospective studies to compare the accuracy and reliability of this novel technique and frozen section analysis.

Berkowitz RS, Goldstein DP. Current management of gestational trophoblastic diseases. Gynecol Oncol 2009; 112: 654-62. http://dx.doi.org/10.1016/j.ygyno.2008.09.005

Garner EI, Goldstein DP, Feltmate CM, Berkowitz RS. Gestational trophoblastic disease. Clin Obstet Gynecol 2007; 50: 112-22. http://dx.doi.org/10.1097/GRF.0b013e31802f17fc

Altieri A, Franceschi S, Ferlay J, Smith J, La Vecchia C. Epidemiology and aetiology of gestational trophoblastic diseases. Lancet Oncol 2003; 4: 670-8. http://dx.doi.org/10.1016/S1470-2045(03)01245-2

teigrad SJ. Epidemiology of gestational trophoblastic diseases. Best Pract Res Clin Obstet Gynaecol 2003; 17: 837-47. http://dx.doi.org/10.1016/S1521-6934(03)00049-X

Moodley M, Tunkyi K, Moodley J. Gestational trophoblastic syndrome: an audit of 112 patients. A South African experience. Int J Gynecol Cancer 2003; 13(2): 234-9. http://dx.doi.org/10.1046/j.1525-1438.2003.13027.x

Disaia PJ, Creasman WT. Gestational trophoblastic neoplasia. In: Clinical Gynecologic Oncology. Vol I. Seventh edition. Edited by Disaia PJ and Creasman WT. Mosby Inc 2007; pp. 201-233.

Cole LA. New discoveries on the biology and detection of human chorionic gonadotropin. Reprod Biol Endocrinol 2009; 7: 8. http://dx.doi.org/10.1186/1477-7827-7-8

Rushworth AG, Orr AH, Bagshawe KD. The concentration of HCG in the plasma and spinal fluid of patients with trophoblastic tumours in the central nervous system. Br J Cancer 1968; 22: 253-257. http://dx.doi.org/10.1038/bjc.1968.33

Vaitukaitis JL, Braunstein GD, Ross GT. A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone. Am J Obstet Gynecol 1972; 113: 751-758.

Stephan JM, Hansen J, Samuelson M, McDonald M, Chin Y, Bender D, Reyes HD, Button A, Goodheart MJ. Intra-operative frozen section results reliably predict final pathology in endometrial cancer. Gynecol Oncol 2014; 133(3): 499-505. http://dx.doi.org/10.1016/j.ygyno.2014.03.569

Ozturk E, Dikensoy E, Balat O, Ugur MG, Aydin A. Intraoperative frozen section is essential for assessment of myometrial invasion but not for histologic grade confirmation in endometrial cancer: a ten-year experience. Arch Gynecol Obstet 2012; 285(5): 1415-9. http://dx.doi.org/10.1007/s00404-011-2135-z

Turan T, Oguz E, Unlubilgin E, Tulunay G, Boran N, Demir OF, Kose MF. Accuracy of frozen-section examination for myometrial invasion and grade in endometrial cancer. Eur J Obstet Gynecol Reprod Biol 2013; 167(1): 90-5. http://dx.doi.org/10.1016/j.ejogrb.2012.11.004

Fox H, Buckley CH. The female genital tract and ovaries. In: McGee JO, Isaacson PG, Wright NA, editors. Oxford text book of pathology. New York: Oxford University Press 1992; pp. 1565-639.

Hemida RA, Toson E, Shalaby H, Refaie E, Sharaf Eldin D. Chemo-resistant gestational trophoblastic neoplasia, 5-years experience of Mansoura University Hospital, Egypt. Open journal of Obstetrics and Gynecology 2011; 1: 153-157. http://dx.doi.org/10.4236/ojog.2011.13029

Doll KM, Soper JT. The role of surgery in the management of gestational trophoblastic neoplasia. Obstet Gynecol Surv 2013; 68(7): 533-42. http://dx.doi.org/10.1097/OGX.0b013e31829a82df

Huang F, Zheng W, Liang Q, Yin T. Diagnosis and treatment of placental site trophoblastic tumor. Int J Clin Exp Pathol 2013; 6(7): 1448-51.

Cheng B, Liu ZX, Zhou W, Qian JH. Fertility-sparing partial hysterectomy for gestational trophoblastic neoplasia: an analysis of 36 cases. J Reprod Med 2014; 59(5-6): 274-8.

Case AM, Wilson S, Colgan TJ, Greenblatt EM. Fertility-sparing surgery, with subsequent pregnancy, in persistent gestational trophoblasticneoplasia: case report. Hum Reprod 2001; 16(2): 360-4. http://dx.doi.org/10.1093/humrep/16.2.360

Mukherjee S, Nagarsenkar A, Chandra S, Sahasrabhojanee M. Primary choriocarcinoma metastasizing to skeletal muscles, presenting as an abdominal wall mass: A rare presentation. J Nat Sci Biol Med 2013; 4(2): 497-9. http://dx.doi.org/10.4103/0976-9668.117001

• PDF